Results 231 to 240 of about 124,278 (281)

One‐Year Survival and Changes in Care Needs Among Hospitalized Older Patients With Coronavirus Disease 2019 in Japan: A Nara Kokuho Database Analysis

Geriatrics &Gerontology International, Volume 26, Issue 2, February 2026.
ABSTRACT Aim The coronavirus disease 2019 (COVID‐19) pandemic has profoundly affected older populations globally. However, limited data are available on the long‐term survival and evolving care needs of older patients with COVID‐19 in Japan. We evaluated 1‐year survival rates and long‐term care needs in this vulnerable population.
Kiyoshi Takemoto, Tomoya Myojin, Yuichi Nishioka, Ikko Yamazaki, Tatsuya Noda, Tomoaki Imamura   +5 more
wiley   +1 more source

Editorial: COVID-19 Six Years on and Endemic Omicron Variants of SARS-CoV-2 Under Monitoring Now Include NB.1.8.1 (Nimbus) and XFG (Stratus). [PDF]

Med Sci Monit
Parums DV.
europepmc   +1 more source

The Impact of COVID‐19 on Dental Hygienists' Stress and Workplace Conditions in Japan

International Journal of Dental Hygiene, Volume 24, Issue 1, Page 108-115, February 2026.
ABSTRACT Objectives The COVID‐19 pandemic emerged in late 2019 and led to unprecedented global lockdowns, disrupting numerous industries, including dentistry. This study aimed to investigate the practicing conditions, personal protective equipment (PPE) usage, and impact of the pandemic on dental hygienists (DHs) in Japan, where strict lockdowns were ...
Rieko Takemae, Hiroteru Okamoto, Masanari Takemae, Zac Morse   +3 more
wiley   +1 more source

Omicron surge impact on acute kidney injury in ICU patients: A study using the ISARIC COVID-19 database. [PDF]

PLoS One
Dai D, Gois PF, Wainstein M, Ghadimi M, Spyrison N, Granado RC, Shrapnel S, Pole JD, ISARIC Characterization Group.   +8 more
europepmc   +1 more source

Humoral epitope dominance and immune imprinting by SARS‐CoV‐1 and SARS‐CoV‐2 vaccines

Immunology &Cell Biology, Volume 104, Issue 2, Page 150-167, February 2026.
We investigated Modified Vaccinia Ankara (MVA) vaccine candidates expressing the SARS‐CoV‐1 or SARS‐CoV‐2 Spike, as a primary or booster immunization, for their ability to induce antibodies targeting different epitopes on the SARS‐CoV‐2 RBD and broad cross‐reactive or cross‐neutralizing responses in C57BL/6 and antibody humanized (Ig‐humanized) mice ...
Deborah L Burnett, Ania Moxon, Anupriya Aggarwal, Katherine JL Jackson, Catherine Cotter, Anouschka Akerman, Amanda Russell, Rachel Kalman, David Langley, Jake Y Henry, Daniel Christ, Rowena A Bull, Robert Brink, Anthony D Kelleher, Hans‐Martin Jäck, Stuart Turville, Bernard Moss, Christopher C Goodnow   +17 more
wiley   +1 more source

Assessment of SARS-CoV-2 immune escape using antigenic cartography combined with experimental challenge studies. [PDF]

NPJ Vaccines
Te Marvelde MR, Mykytyn AZ, Veldhuis Kroeze EJB, Bouffier AHJ, van Eck-Schipper D, van den Doel P, Handrejk K, Koel B, Rissmann M, Haagmans BL.   +9 more
europepmc   +1 more source

Impact of the COVID‐19 Pandemic on Mortality Patterns in Bushehr Port of Iran: A Comparative Analysis of the Prepandemic Period (2014–2019) and the Pandemic Era (2020–2023)

Influenza and Other Respiratory Viruses, Volume 20, Issue 2, February 2026.
ABSTRACT Background Industrial and coastal regions may experience unique pandemic‐related mortality patterns, yet data from Middle Eastern occupational cohorts are extremely limited. Methods In this retrospective cohort study, we analyzed 58,976 deaths in Bushehr Province, Iran (2014–2023).
Ali Soleimaninejad, Mouhebat Vali, Mohammad Al Qadire, Abdolrahim Asadollahi   +3 more
wiley   +1 more source

Assessing COVID-19 Infection and Severe Disease Risk in Cancer Patients and Survivors: The Role of Vaccination Status, Circulating Variants, and Comorbidities-A Population-Based Study in Northern Italy. [PDF]

Vaccines (Basel)
Vicentini M, Mancuso P, Venturelli F, Mezzadri S, Bisaccia E, Zerbini A, Mangone L, Giorgi Rossi P, On Behalf Of The Reggio Emilia Covid-Working Group.   +8 more
europepmc   +1 more source